Drug recall · September 29, 2021
Metoprolol Tartrate Tablets USP 100 mg recall
Why: Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520, NDC 65862-064-99
- Lots / codes
Lot: MJ1019025-A, Exp. date 04/2022
- Quantity
- 2,820 bottles
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- Nationwide within the United States
- Initiated
- September 9, 2021 · Voluntary: Firm initiated
- Classified
- September 20, 2021
- Reported
- September 29, 2021
- Ended
- October 31, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.